nodes	percent_of_prediction	percent_of_DWPC	metapath
Amantadine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0882	0.132	CbGbCtD
Amantadine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0857	0.128	CbGbCtD
Amantadine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0855	0.128	CbGbCtD
Amantadine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0775	0.116	CbGbCtD
Amantadine—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0661	0.0991	CbGbCtD
Amantadine—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0575	0.0861	CbGbCtD
Amantadine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0346	0.0519	CbGbCtD
Amantadine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0313	0.0469	CbGbCtD
Amantadine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.027	0.0405	CbGbCtD
Amantadine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0262	0.0393	CbGbCtD
Amantadine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0237	0.0356	CbGbCtD
Amantadine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0237	0.0356	CbGbCtD
Amantadine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0228	0.0341	CbGbCtD
Amantadine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0176	0.0264	CbGbCtD
Amantadine—GRIN2C—nerve—acquired immunodeficiency syndrome	0.00767	0.08	CbGeAlD
Amantadine—GRIN2B—nerve—acquired immunodeficiency syndrome	0.00607	0.0632	CbGeAlD
Amantadine—GRIN2A—nerve—acquired immunodeficiency syndrome	0.0053	0.0553	CbGeAlD
Amantadine—DDC—nerve—acquired immunodeficiency syndrome	0.00495	0.0516	CbGeAlD
Amantadine—GRIN3B—lung—acquired immunodeficiency syndrome	0.00388	0.0404	CbGeAlD
Amantadine—DDC—blood plasma—acquired immunodeficiency syndrome	0.00375	0.039	CbGeAlD
Amantadine—MAOB—nerve—acquired immunodeficiency syndrome	0.00255	0.0266	CbGeAlD
Amantadine—DRD2—nerve—acquired immunodeficiency syndrome	0.00215	0.0224	CbGeAlD
Amantadine—MAOB—blood plasma—acquired immunodeficiency syndrome	0.00193	0.0201	CbGeAlD
Amantadine—GRIN2D—spinal cord—acquired immunodeficiency syndrome	0.0019	0.0198	CbGeAlD
Amantadine—GRIN2C—nervous system—acquired immunodeficiency syndrome	0.00173	0.018	CbGeAlD
Amantadine—GRIN1—spinal cord—acquired immunodeficiency syndrome	0.0017	0.0177	CbGeAlD
Amantadine—GRIN2C—central nervous system—acquired immunodeficiency syndrome	0.00166	0.0173	CbGeAlD
Amantadine—GRIN2B—spinal cord—acquired immunodeficiency syndrome	0.00162	0.0169	CbGeAlD
Amantadine—GRIN2D—nervous system—acquired immunodeficiency syndrome	0.0016	0.0167	CbGeAlD
Amantadine—GRIN2D—central nervous system—acquired immunodeficiency syndrome	0.00154	0.0161	CbGeAlD
Amantadine—GRIN3A—nervous system—acquired immunodeficiency syndrome	0.00151	0.0157	CbGeAlD
Amantadine—GRIN3A—central nervous system—acquired immunodeficiency syndrome	0.00145	0.0151	CbGeAlD
Amantadine—GRIN1—nervous system—acquired immunodeficiency syndrome	0.00143	0.0149	CbGeAlD
Amantadine—GRIN2A—spinal cord—acquired immunodeficiency syndrome	0.00142	0.0147	CbGeAlD
Amantadine—GRIN1—central nervous system—acquired immunodeficiency syndrome	0.00138	0.0143	CbGeAlD
Amantadine—GRIN2B—nervous system—acquired immunodeficiency syndrome	0.00136	0.0142	CbGeAlD
Amantadine—GRIN2A—vagina—acquired immunodeficiency syndrome	0.00136	0.0142	CbGeAlD
Amantadine—GRIN2C—brain—acquired immunodeficiency syndrome	0.00132	0.0137	CbGeAlD
Amantadine—GRIN2B—central nervous system—acquired immunodeficiency syndrome	0.00131	0.0137	CbGeAlD
Amantadine—GRIN2D—brain—acquired immunodeficiency syndrome	0.00123	0.0128	CbGeAlD
Amantadine—DDC—lung—acquired immunodeficiency syndrome	0.0012	0.0125	CbGeAlD
Amantadine—GRIN2A—nervous system—acquired immunodeficiency syndrome	0.00119	0.0124	CbGeAlD
Amantadine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.00119	0.0124	CbGeAlD
Amantadine—GRIN3A—brain—acquired immunodeficiency syndrome	0.00115	0.012	CbGeAlD
Amantadine—GRIN2A—central nervous system—acquired immunodeficiency syndrome	0.00115	0.012	CbGeAlD
Amantadine—DDC—nervous system—acquired immunodeficiency syndrome	0.00111	0.0116	CbGeAlD
Amantadine—GRIN1—brain—acquired immunodeficiency syndrome	0.00109	0.0114	CbGeAlD
Amantadine—DDC—central nervous system—acquired immunodeficiency syndrome	0.00107	0.0112	CbGeAlD
Amantadine—GRIN2B—brain—acquired immunodeficiency syndrome	0.00104	0.0109	CbGeAlD
Amantadine—GRIN2A—brain—acquired immunodeficiency syndrome	0.000911	0.0095	CbGeAlD
Amantadine—DRD2—retina—acquired immunodeficiency syndrome	0.000891	0.00928	CbGeAlD
Amantadine—DDC—brain—acquired immunodeficiency syndrome	0.000852	0.00887	CbGeAlD
Amantadine—DDC—lymph node—acquired immunodeficiency syndrome	0.000823	0.00858	CbGeAlD
Amantadine—SLC22A1—blood—acquired immunodeficiency syndrome	0.000798	0.00832	CbGeAlD
Amantadine—MAOB—digestive system—acquired immunodeficiency syndrome	0.000741	0.00772	CbGeAlD
Amantadine—SLC22A1—vagina—acquired immunodeficiency syndrome	0.00074	0.00771	CbGeAlD
Amantadine—SIGMAR1—blood—acquired immunodeficiency syndrome	0.000738	0.00769	CbGeAlD
Amantadine—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.000714	0.00744	CbGeAlD
Amantadine—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.000711	0.00741	CbGeAlD
Amantadine—MAOB—blood—acquired immunodeficiency syndrome	0.000706	0.00736	CbGeAlD
Amantadine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000703	0.00733	CbGeAlD
Amantadine—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.000684	0.00712	CbGeAlD
Amantadine—MAOB—spinal cord—acquired immunodeficiency syndrome	0.00068	0.00709	CbGeAlD
Amantadine—MAOB—vagina—acquired immunodeficiency syndrome	0.000654	0.00682	CbGeAlD
Amantadine—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000648	0.00675	CbGeAlD
Amantadine—SIGMAR1—lung—acquired immunodeficiency syndrome	0.000647	0.00674	CbGeAlD
Amantadine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000624	0.0065	CbGeAlD
Amantadine—MAOB—lung—acquired immunodeficiency syndrome	0.000619	0.00645	CbGeAlD
Amantadine—MAOB—nervous system—acquired immunodeficiency syndrome	0.000573	0.00597	CbGeAlD
Amantadine—MAOB—central nervous system—acquired immunodeficiency syndrome	0.000552	0.00575	CbGeAlD
Amantadine—DRD2—lung—acquired immunodeficiency syndrome	0.000522	0.00544	CbGeAlD
Amantadine—SLC22A1—brain—acquired immunodeficiency syndrome	0.000495	0.00516	CbGeAlD
Amantadine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000484	0.00504	CbGeAlD
Amantadine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000466	0.00485	CbGeAlD
Amantadine—SIGMAR1—brain—acquired immunodeficiency syndrome	0.000458	0.00477	CbGeAlD
Amantadine—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000442	0.00461	CbGeAlD
Amantadine—MAOB—brain—acquired immunodeficiency syndrome	0.000438	0.00457	CbGeAlD
Amantadine—MAOB—lymph node—acquired immunodeficiency syndrome	0.000423	0.00441	CbGeAlD
Amantadine—ABCB1—retina—acquired immunodeficiency syndrome	0.000385	0.00401	CbGeAlD
Amantadine—DRD2—brain—acquired immunodeficiency syndrome	0.00037	0.00385	CbGeAlD
Amantadine—Confusional state—Efavirenz—acquired immunodeficiency syndrome	0.000302	0.00127	CcSEcCtD
Amantadine—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.0003	0.00127	CcSEcCtD
Amantadine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000299	0.00126	CcSEcCtD
Amantadine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000298	0.00126	CcSEcCtD
Amantadine—Malnutrition—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.00126	CcSEcCtD
Amantadine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000297	0.00126	CcSEcCtD
Amantadine—Decreased appetite—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00125	CcSEcCtD
Amantadine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000294	0.00124	CcSEcCtD
Amantadine—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000294	0.00124	CcSEcCtD
Amantadine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000293	0.00124	CcSEcCtD
Amantadine—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.00124	CcSEcCtD
Amantadine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00124	CcSEcCtD
Amantadine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000292	0.00124	CcSEcCtD
Amantadine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000292	0.00123	CcSEcCtD
Amantadine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.00123	CcSEcCtD
Amantadine—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.00123	CcSEcCtD
Amantadine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000291	0.00123	CcSEcCtD
Amantadine—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.00123	CcSEcCtD
Amantadine—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.00123	CcSEcCtD
Amantadine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.000289	0.00122	CcSEcCtD
Amantadine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00122	CcSEcCtD
Amantadine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000289	0.00122	CcSEcCtD
Amantadine—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000289	0.00122	CcSEcCtD
Amantadine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000289	0.00122	CcSEcCtD
Amantadine—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000287	0.00121	CcSEcCtD
Amantadine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000287	0.00121	CcSEcCtD
Amantadine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000287	0.00121	CcSEcCtD
Amantadine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000287	0.00121	CcSEcCtD
Amantadine—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000286	0.00121	CcSEcCtD
Amantadine—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000286	0.00121	CcSEcCtD
Amantadine—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00121	CcSEcCtD
Amantadine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000284	0.0012	CcSEcCtD
Amantadine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000284	0.0012	CcSEcCtD
Amantadine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000284	0.0012	CcSEcCtD
Amantadine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000284	0.0012	CcSEcCtD
Amantadine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000283	0.00119	CcSEcCtD
Amantadine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000282	0.00119	CcSEcCtD
Amantadine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000282	0.00119	CcSEcCtD
Amantadine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000281	0.00119	CcSEcCtD
Amantadine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000281	0.00119	CcSEcCtD
Amantadine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00119	CcSEcCtD
Amantadine—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.00028	0.00119	CcSEcCtD
Amantadine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00118	CcSEcCtD
Amantadine—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00118	CcSEcCtD
Amantadine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.00118	CcSEcCtD
Amantadine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00118	CcSEcCtD
Amantadine—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000279	0.00118	CcSEcCtD
Amantadine—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.00118	CcSEcCtD
Amantadine—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000278	0.00117	CcSEcCtD
Amantadine—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000277	0.00117	CcSEcCtD
Amantadine—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000277	0.00117	CcSEcCtD
Amantadine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000277	0.00117	CcSEcCtD
Amantadine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000277	0.00117	CcSEcCtD
Amantadine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000275	0.00116	CcSEcCtD
Amantadine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000275	0.00116	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000274	0.00116	CcSEcCtD
Amantadine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000274	0.00285	CbGeAlD
Amantadine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000273	0.00116	CcSEcCtD
Amantadine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000273	0.00115	CcSEcCtD
Amantadine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000273	0.00115	CcSEcCtD
Amantadine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.00115	CcSEcCtD
Amantadine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000271	0.00114	CcSEcCtD
Amantadine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00027	0.00114	CcSEcCtD
Amantadine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00114	CcSEcCtD
Amantadine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.00027	0.00282	CbGeAlD
Amantadine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00027	0.00114	CcSEcCtD
Amantadine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000269	0.00114	CcSEcCtD
Amantadine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000269	0.00114	CcSEcCtD
Amantadine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000269	0.00114	CcSEcCtD
Amantadine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000269	0.00114	CcSEcCtD
Amantadine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000268	0.00113	CcSEcCtD
Amantadine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000268	0.00113	CcSEcCtD
Amantadine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.00113	CcSEcCtD
Amantadine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000267	0.00113	CcSEcCtD
Amantadine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000267	0.00113	CcSEcCtD
Amantadine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.00113	CcSEcCtD
Amantadine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000266	0.00112	CcSEcCtD
Amantadine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000265	0.00112	CcSEcCtD
Amantadine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000265	0.00112	CcSEcCtD
Amantadine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000264	0.00112	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000264	0.00112	CcSEcCtD
Amantadine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000263	0.00111	CcSEcCtD
Amantadine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000261	0.0011	CcSEcCtD
Amantadine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.0011	CcSEcCtD
Amantadine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.00026	0.0011	CcSEcCtD
Amantadine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.00026	0.0011	CcSEcCtD
Amantadine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.0011	CcSEcCtD
Amantadine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000259	0.00109	CcSEcCtD
Amantadine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000259	0.00109	CcSEcCtD
Amantadine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.00109	CcSEcCtD
Amantadine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00109	CcSEcCtD
Amantadine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00109	CcSEcCtD
Amantadine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000258	0.00109	CcSEcCtD
Amantadine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000258	0.00109	CcSEcCtD
Amantadine—ABCB1—blood—acquired immunodeficiency syndrome	0.000258	0.00268	CbGeAlD
Amantadine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.00109	CcSEcCtD
Amantadine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000257	0.00109	CcSEcCtD
Amantadine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000257	0.00109	CcSEcCtD
Amantadine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.00108	CcSEcCtD
Amantadine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.00108	CcSEcCtD
Amantadine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000256	0.00108	CcSEcCtD
Amantadine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000255	0.00108	CcSEcCtD
Amantadine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000255	0.00108	CcSEcCtD
Amantadine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000255	0.00108	CcSEcCtD
Amantadine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000255	0.00108	CcSEcCtD
Amantadine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000254	0.00108	CcSEcCtD
Amantadine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000254	0.00107	CcSEcCtD
Amantadine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000253	0.00107	CcSEcCtD
Amantadine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00107	CcSEcCtD
Amantadine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.00106	CcSEcCtD
Amantadine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000252	0.00106	CcSEcCtD
Amantadine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00025	0.00106	CcSEcCtD
Amantadine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00025	0.00106	CcSEcCtD
Amantadine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00025	0.00106	CcSEcCtD
Amantadine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000249	0.0026	CbGeAlD
Amantadine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000249	0.00105	CcSEcCtD
Amantadine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.00105	CcSEcCtD
Amantadine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000248	0.00259	CbGeAlD
Amantadine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000248	0.00105	CcSEcCtD
Amantadine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000248	0.00105	CcSEcCtD
Amantadine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000247	0.00105	CcSEcCtD
Amantadine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.00105	CcSEcCtD
Amantadine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00105	CcSEcCtD
Amantadine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.00104	CcSEcCtD
Amantadine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000247	0.00104	CcSEcCtD
Amantadine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000247	0.00104	CcSEcCtD
Amantadine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000247	0.00104	CcSEcCtD
Amantadine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000246	0.00104	CcSEcCtD
Amantadine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00104	CcSEcCtD
Amantadine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000246	0.00104	CcSEcCtD
Amantadine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000245	0.00104	CcSEcCtD
Amantadine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000245	0.00104	CcSEcCtD
Amantadine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000245	0.00104	CcSEcCtD
Amantadine—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00103	CcSEcCtD
Amantadine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.00103	CcSEcCtD
Amantadine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000243	0.00103	CcSEcCtD
Amantadine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000243	0.00103	CcSEcCtD
Amantadine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00103	CcSEcCtD
Amantadine—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000243	0.00103	CcSEcCtD
Amantadine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00103	CcSEcCtD
Amantadine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000242	0.00102	CcSEcCtD
Amantadine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000241	0.00102	CcSEcCtD
Amantadine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000241	0.00102	CcSEcCtD
Amantadine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000239	0.00101	CcSEcCtD
Amantadine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000239	0.00249	CbGeAlD
Amantadine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.00101	CcSEcCtD
Amantadine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00101	CcSEcCtD
Amantadine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000238	0.001	CcSEcCtD
Amantadine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000236	0.001	CcSEcCtD
Amantadine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000998	CcSEcCtD
Amantadine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000236	0.000997	CcSEcCtD
Amantadine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000236	0.000997	CcSEcCtD
Amantadine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000235	0.000995	CcSEcCtD
Amantadine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.000993	CcSEcCtD
Amantadine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000233	0.000986	CcSEcCtD
Amantadine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000233	0.000986	CcSEcCtD
Amantadine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.000985	CcSEcCtD
Amantadine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000233	0.000985	CcSEcCtD
Amantadine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000233	0.000983	CcSEcCtD
Amantadine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000979	CcSEcCtD
Amantadine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.00023	0.000974	CcSEcCtD
Amantadine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000973	CcSEcCtD
Amantadine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000229	0.000969	CcSEcCtD
Amantadine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000229	0.000967	CcSEcCtD
Amantadine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000966	CcSEcCtD
Amantadine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000228	0.000965	CcSEcCtD
Amantadine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000227	0.00096	CcSEcCtD
Amantadine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000227	0.00096	CcSEcCtD
Amantadine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00096	CcSEcCtD
Amantadine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000226	0.000957	CcSEcCtD
Amantadine—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000957	CcSEcCtD
Amantadine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000226	0.000956	CcSEcCtD
Amantadine—ABCB1—lung—acquired immunodeficiency syndrome	0.000226	0.00235	CbGeAlD
Amantadine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000225	0.000952	CcSEcCtD
Amantadine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000948	CcSEcCtD
Amantadine—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000224	0.000947	CcSEcCtD
Amantadine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000936	CcSEcCtD
Amantadine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00022	0.000932	CcSEcCtD
Amantadine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.00093	CcSEcCtD
Amantadine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00022	0.000929	CcSEcCtD
Amantadine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00022	0.000928	CcSEcCtD
Amantadine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000218	0.000922	CcSEcCtD
Amantadine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000218	0.000922	CcSEcCtD
Amantadine—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000921	CcSEcCtD
Amantadine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000217	0.000916	CcSEcCtD
Amantadine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000217	0.000916	CcSEcCtD
Amantadine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000216	0.000915	CcSEcCtD
Amantadine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000216	0.000913	CcSEcCtD
Amantadine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000215	0.000907	CcSEcCtD
Amantadine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.000907	CcSEcCtD
Amantadine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000214	0.000906	CcSEcCtD
Amantadine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000904	CcSEcCtD
Amantadine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000213	0.000902	CcSEcCtD
Amantadine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000895	CcSEcCtD
Amantadine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000893	CcSEcCtD
Amantadine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000211	0.000891	CcSEcCtD
Amantadine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000887	CcSEcCtD
Amantadine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00021	0.000887	CcSEcCtD
Amantadine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000886	CcSEcCtD
Amantadine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000209	0.000885	CcSEcCtD
Amantadine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000209	0.000884	CcSEcCtD
Amantadine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000209	0.00218	CbGeAlD
Amantadine—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000878	CcSEcCtD
Amantadine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000868	CcSEcCtD
Amantadine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000865	CcSEcCtD
Amantadine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000856	CcSEcCtD
Amantadine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.000855	CcSEcCtD
Amantadine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000201	0.000851	CcSEcCtD
Amantadine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000201	0.0021	CbGeAlD
Amantadine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000851	CcSEcCtD
Amantadine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.0002	0.000847	CcSEcCtD
Amantadine—Rash—Indinavir—acquired immunodeficiency syndrome	0.0002	0.000844	CcSEcCtD
Amantadine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000843	CcSEcCtD
Amantadine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000838	CcSEcCtD
Amantadine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000198	0.000836	CcSEcCtD
Amantadine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000828	CcSEcCtD
Amantadine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000824	CcSEcCtD
Amantadine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000812	CcSEcCtD
Amantadine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000804	CcSEcCtD
Amantadine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000803	CcSEcCtD
Amantadine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000189	0.0008	CcSEcCtD
Amantadine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.000797	CcSEcCtD
Amantadine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000797	CcSEcCtD
Amantadine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000795	CcSEcCtD
Amantadine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000793	CcSEcCtD
Amantadine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000792	CcSEcCtD
Amantadine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000792	CcSEcCtD
Amantadine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000773	CcSEcCtD
Amantadine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000769	CcSEcCtD
Amantadine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000765	CcSEcCtD
Amantadine—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000763	CcSEcCtD
Amantadine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00018	0.000762	CcSEcCtD
Amantadine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000762	CcSEcCtD
Amantadine—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000758	CcSEcCtD
Amantadine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000757	CcSEcCtD
Amantadine—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.000751	CcSEcCtD
Amantadine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00074	CcSEcCtD
Amantadine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000737	CcSEcCtD
Amantadine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000737	CcSEcCtD
Amantadine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000727	CcSEcCtD
Amantadine—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000719	CcSEcCtD
Amantadine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.000712	CcSEcCtD
Amantadine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000711	CcSEcCtD
Amantadine—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000705	CcSEcCtD
Amantadine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.000705	CcSEcCtD
Amantadine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000703	CcSEcCtD
Amantadine—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000701	CcSEcCtD
Amantadine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000685	CcSEcCtD
Amantadine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.000679	CcSEcCtD
Amantadine—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000679	CcSEcCtD
Amantadine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000678	CcSEcCtD
Amantadine—ABCB1—brain—acquired immunodeficiency syndrome	0.00016	0.00167	CbGeAlD
Amantadine—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000675	CcSEcCtD
Amantadine—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000665	CcSEcCtD
Amantadine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000653	CcSEcCtD
Amantadine—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000154	0.00161	CbGeAlD
Amantadine—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000648	CcSEcCtD
Amantadine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000153	0.000647	CcSEcCtD
Amantadine—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000644	CcSEcCtD
Amantadine—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.00064	CcSEcCtD
Amantadine—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00061	CcSEcCtD
